Kamada Ltd (KMDA) reports a 13% revenue increase and unveils plans for biosimilar launches and plasma center expansions.

Q4 2024 Earnings Call Transcript March 5, 2025 EyePoint Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is $-0.64 EPS, expectations were $-0.54. Tessa Romero – JPMorgan: Yigal ...

M, +43% v. 2023; 4Q 2024 revenues of $77M, +31% v. 4Q 20232024 net income of $28M; Non-GAAP net income of $68M 4Q 2024 net ...

Q4 2024 Earnings Call Transcript March 5, 2025 Kamada Ltd. beats earnings expectations. Reported EPS is $0.07, expectations ...

Record Year with Total 2024 Revenuesof $161.0Million, Representing a 13% Increase over Fiscal Year 2023 and Adjusted EBITDA of $34.1 Million, Up ...

Institutional Class shares of Columbia Dividend Income Fund returned -1.34% for Q4 2024. Click here to read the full ...

Read here for 5 dividend stocks that offer a rare combination of high yields, wide moats, strong balance sheets, and growing ...

Organogenesis ( ORGO -5.54%) Q4 2024 Earnings Call Feb 27, 2025, 5:00 p.m. ET ...

In a loss update ahead of its Q4 and full year 2024 earnings, specialty insurer Fidelis Insurance Holdings Limited has reported net adverse prior year ...

Former soccer leaders Sepp Blatter and Michel Platini are back in a Swiss court as their new trial on fraud, forgery and ...

Aviation litigation stemming from the Russia-Ukraine conflict is having an impact on the profits of Bermudian-based global ...